Oxazole-based ferroptosis inhibitors with promising properties to treat central nervous system diseases
Source
Journal of medicinal chemistry - ISSN 0022-2623-68:4 (2025) p. 4908-4928
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Source
Cell death and differentiation - ISSN 1350-9047-31 (2024) p. 1113-1126
Therapeutic exploitation of ferroptosis
Source
Biochemical Society transactions - ISSN 0300-5127- (2024) p.